Home › Funds › Transmarket Holdings LP › GSK
Transmarket Holdings LP position in GSK
GSK PLC · Health Care
Transmarket Holdings LP reported holding 188,473 shares of GSK (GSK PLC) in its Q2 2026 13F filing — a position valued at US$9.9M, representing 7.25% of its reported portfolio and ranking #3 among its reported holdings. Transmarket Holdings LP has disclosed GSK holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
How Transmarket Holdings LP's GSK position evolved
Transmarket Holdings LP first disclosed a stake in GSK in Q4 2025 at 27,816 shares (US$1.4M). The position peaked in Q1 2026 at 222,457 shares, worth US$12.3M. Across 3 filings, Transmarket Holdings LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 188,473 shares valued at US$9.9M — a reduction of -33,984 shares quarter over quarter.. Notable position changes include a 700% increase in Q1 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 27.82K | $1.36M | New |
| Q1 2026 | 222.46K | $12.28M | Add |
| Q2 2026 | 188.47K | $9.88M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026